ArticleThe American journal of case reports2024

Pathological Complete Response with Neoadjuvant Trastuzumab, Pertuzumab, and Chemotherapy Followed by Modified Radical Mastectomy in a Patient with HER2-Positive Occult Breast Cancer.

Chunchun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.